The Crohn’s Disease Market in 2023 is US$ 11.54 billion, and is expected to reach US$ 15.69 billion by 2031 at a CAGR of 3.92%. FutureWise Research published a report that analyzes Crohn’s Disease Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the...

Gastrointestinal Therapeutics Industry The global gastrointestinal therapeutics market size is expected to reach USD 48.61 billion by 2030, advancing at a CAGR of 3.3% during the forecast period, as per a new report by Grand View Research, Inc. Unhealthy eating habits, coupled with a sedentary lifestyle, have led to the development of gastrointestinal diseases among consumers, which...

The global Gastrointestinal Therapeutics Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2022-2030. Most importantly, this report also provides the latest significant strategies adopted by major players...

COVID-19 Impact Analysis on Ulcerative Colitis Market report published by Value Market Research provides a detailed market analysis comprising market size, share, value, growth and trends for the period 2022-2030. The report encompasses data regarding market share and recent developments by key players. Moreover, this market report also covers regional and country markets in detail. The...

The global ulcerative colitis therapeutics market is valued at USD 7.2 billion in 2025. As per Fact.MR analysis, the industry will grow at a CAGR of 5.1% and will reach USD 11.9 billion by 2035. Ulcerative colitis, a type of chronic inflammatory bowel disease, causes acute inflammation and ulceration in the large bowel and rectum. In 2024, the therapeutics industry for ulcerative...

The global ulcerative colitis therapeutics market is valued at USD 7.2 billion in 2025. As per Fact.MR analysis, the industry will grow at a CAGR of 5.1% and will reach USD 11.9 billion by 2035. Ulcerative colitis, a type of chronic inflammatory bowel disease, causes acute inflammation and ulceration in the large bowel and rectum. In 2024, the therapeutics industry for ulcerative...